ID   STR-I-233-FRAXA
AC   CVCL_C091
SY   STR-233-FRAXA; INSERMe002-A; INSRMe002-A
DR   hPSCreg; INSRMe002-A
DR   ISCR; 1270
DR   SKIP; SKIP002309
DR   Wikidata; Q54970625
RX   PubMed=20217271;
RX   PubMed=27690107;
WW   https://www.agence-biomedecine.fr/IMG/pdf/inserm_str_i_233_fraxa.pdf
CC   From: INSERM; Paris; France.
CC   Registration: French Agence de la Biomedecine; FE08-087-L1.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C84717; Fragile X syndrome
DI   ORDO; Orphanet_908; Fragile X syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 14
//
RX   PubMed=20217271; DOI=10.1007/s11626-010-9300-8;
RA   Tropel P., Tournois J., Come J., Varela C., Moutou C., Fragner P.,
RA   Cailleret M., Laabi Y., Peschanski M., Viville S.;
RT   "High-efficiency derivation of human embryonic stem cell lines
RT   following pre-implantation genetic diagnosis.";
RL   In Vitro Cell. Dev. Biol. Anim. 46:376-385(2010).
//
RX   PubMed=27690107; DOI=10.3390/genes7100077;
RA   Mor-Shaked H., Eiges R.;
RT   "Modeling fragile X syndrome using human pluripotent stem cells.";
RL   Genes (Basel) 7:77.1-77.19(2016).
//